Supplementary Table 1 from AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer

MLA

Sandra Van Schaeybroeck, et al. Supplementary Table 1 from AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22449098.

APA

Sandra Van Schaeybroeck, Patrick G. Johnston, Manuel Salto-Tellez, Daniel B. Longley, Keara Redmond, Maurice Loughrey, Ken Arthur, Chee Wee Ong, Supriya Srivastava, Tingting Wang, Samanda Greer, Murugan Kalimutho, Jaine K. Blayney, Darragh G. McArt, & Philip D. Dunne. (2023). Supplementary Table 1 from AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer. https://doi.org/10.1158/1078-0432.22449098

Chicago

Sandra Van Schaeybroeck, Patrick G. Johnston, Manuel Salto-Tellez, Daniel B. Longley, Keara Redmond, Maurice Loughrey, Ken Arthur, et al. 2023. “Supplementary Table 1 from AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer,” March. doi:10.1158/1078-0432.22449098.